Our multi-institutional collaboration identifying mechanisms of acquired resistance to KRAS G12C inhibitors in cancer is now out @NEJM. This thread highlights our key findings. @andrewaguirre @DanaFarber
Mark Awad
@DrMarkAwad
Chief, Thoracic Oncology, Memorial Sloan Kettering Cancer Center @MSKCancerCenter | Lung Cancer Immunotherapy Research | Tweets my own
